The product name of the Reda (Invega) is a 薬 of atypical antipsychotics developed by Johnson-Yeung pharmaceutical. Reda is a long-term version of the Oros, which is administered by a permeable controlled-release oral delivery system, allowing patients to take one day. Chemically, it is the main activity of 薬 risperidone metabolism in early-stage atypical antipsychotics. The drug is used to treat schizophrenia and to divide affective disorders. The use of prescription, including Tourette's, can be significantly improved with low doses.